Celldex Therapeutics Inc. (CLDX) current stock price is $27.23. During the last trading session, the stock soared, reaching $29.56 after opening at $29.06. The stock’s lowest point was $26.92 before it closed at $29.09.
In terms of market performance, Celldex Therapeutics Inc. had a somewhat inconsistent run in. The highest value for the stock in the past year was $48.40 on 01/18/23, while the lowest value was $22.11 on 10/30/23.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
52-week price history of CLDX Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Celldex Therapeutics Inc.’s current trading price is -43.74% away from its 52-week high, while its distance from the 52-week low is 23.16%. The stock’s price range for this period has remained between $22.11 and $48.40. The Healthcare sector company’s shares managed to surpass a trading volume of around 1.73 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.69 million over the last three months.
Financial Performance and Market Capitalization
Celldex Therapeutics Inc. (CLDX) has experienced a quarterly decline of -6.04% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.49B and boasts a workforce of 148 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 29.48, with a change in price of -7.35. Similarly, Celldex Therapeutics Inc. recorded 595,687 in trading volume during the last 100 days, posting a change of -21.26%.
CLDX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CLDX stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.
CLDX Stock Stochastic Average
As of today, the raw stochastic average of Celldex Therapeutics Inc. over the past 50 days is 44.76%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 44.76%. Additionally, the Stochastic %K and %D values for the company were 51.81% and 53.18%, respectively, over the past 20 days.
CLDX Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Until today this year the stock’s price performance recorded a decrease of -38.91%. However, over the last six months, the performance has been stronger by -19.01%. The price of CLDX increased 11.46% over the last 30 days. And in the last five days, it has surged by 0.96%.
